Significant efficacy and well safety of apatinib in an advanced liver cancer patient: a case report and literature review

Apatinib is a novel and highly selective tyrosine kinase inhibitor of vascular endothelial growth factor receptor-2. Previous studies have suggested that apatinib is safe and effective in some solid tumors. We report one case with advanced hepatocellular carcinoma (HCC), who received apatinib combin...

Descripción completa

Detalles Bibliográficos
Autores principales: Kou, Peisi, Zhang, Yan, Shao, Wenbo, Zhu, Hui, Zhang, Jingze, Wang, Haiyong, Kong, Li, Yu, Jinming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386780/
https://www.ncbi.nlm.nih.gov/pubmed/28103584
http://dx.doi.org/10.18632/oncotarget.14724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386780/
https://www.ncbi.nlm.nih.gov/pubmed/28103584
http://dx.doi.org/10.18632/oncotarget.14724

Ejemplares similares